The Q


Journal

ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580

Informations de publication

Date de publication:
13 03 2020
Historique:
pubmed: 23 1 2020
medline: 28 1 2021
entrez: 23 1 2020
Statut: ppublish

Résumé

Available treatments for Chagas' disease and visceral leishmaniasis are inadequate, and there is a pressing need for new therapeutics. Drug discovery efforts for both diseases principally rely upon phenotypic screening. However, the optimization of phenotypically active compounds is hindered by a lack of information regarding their molecular target(s). To combat this issue we initiate target deconvolution studies at an early stage. Here, we describe comprehensive genetic and biochemical studies to determine the targets of three unrelated phenotypically active compounds. All three structurally diverse compounds target the Q

Identifiants

pubmed: 31967783
doi: 10.1021/acsinfecdis.9b00426
pmc: PMC7076694
doi:

Substances chimiques

Antiparasitic Agents 0
Cytochromes b 9035-37-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-528

Subventions

Organisme : Wellcome Trust
ID : 203134
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204672/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 092340
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 105021
Pays : United Kingdom

Références

mBio. 2018 Oct 9;9(5):
pubmed: 30301850
J Biol Chem. 1988 Sep 5;263(25):12564-70
pubmed: 2842335
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
FEMS Yeast Res. 2008 Mar;8(2):183-92
pubmed: 18093133
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Mol Biochem Parasitol. 2003 Aug 11;130(1):31-42
pubmed: 14550894
Science. 2016 Apr 15;352(6283):349-53
pubmed: 27081071
J Biol Chem. 1989 Oct 25;264(30):17770-6
pubmed: 2808350
J Med Chem. 2013 Oct 24;56(20):7719-26
pubmed: 24015767
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118
ACS Chem Biol. 2011 Nov 18;6(11):1214-22
pubmed: 21866942
PLoS Negl Trop Dis. 2018 Jul 12;12(7):e0006612
pubmed: 30001347
J Clin Invest. 2008 Apr;118(4):1301-10
pubmed: 18382742
Bioinformatics. 2012 Feb 15;28(4):464-9
pubmed: 22199388
Sci Rep. 2015 Mar 05;5:8771
pubmed: 25740547
Cell. 1990 Jun 1;61(5):879-84
pubmed: 1693097
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
Chem Biol. 2011 Dec 23;18(12):1602-10
pubmed: 22195562
PLoS One. 2012;7(12):e52951
pubmed: 23300833
PLoS Pathog. 2015 Jul 17;11(7):e1005058
pubmed: 26186534
Clin Infect Dis. 2013 Jun;56(11):1530-8
pubmed: 23425958
J Chem Theory Comput. 2016 Jan 12;12(1):281-96
pubmed: 26584231
J Mol Biol. 2000 Sep 8;302(1):205-17
pubmed: 10964570
Nature. 2018 Aug;560(7717):192-197
pubmed: 30046105
Pest Manag Sci. 2002 Feb;58(2):139-45
pubmed: 11852638
PLoS Negl Trop Dis. 2015 Sep 22;9(9):e0004014
pubmed: 26394211
Biochem Pharmacol. 2010 Nov 15;80(10):1478-86
pubmed: 20696141
Eukaryot Cell. 2002 Aug;1(4):495-502
pubmed: 12455998
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Eur J Biochem. 1994 Dec 15;226(3):1019-27
pubmed: 7813456
J Antimicrob Chemother. 2018 Apr 1;73(4):1060-1067
pubmed: 29351667
J Med Chem. 2017 Sep 14;60(17):7284-7299
pubmed: 28844141
Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9616-9621
pubmed: 30185555
Parasitology. 2014 Jan;141(1):140-6
pubmed: 23985066
J Mol Biol. 2005 Aug 19;351(3):573-97
pubmed: 16024040
Antimicrob Agents Chemother. 2013 Jul;57(7):2913-22
pubmed: 23571538
N Engl J Med. 2014 May 15;370(20):1899-908
pubmed: 24827034
Expert Rev Anti Infect Ther. 2006 Apr;4(2):177-85
pubmed: 16597200
Biochem J. 2014 Apr 15;459(2):323-32
pubmed: 24444291
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9318-9323
pubmed: 30962368
J Biol Chem. 2006 Nov 24;281(47):36036-43
pubmed: 16987808
Nature. 1998 Apr 16;392(6677):677-84
pubmed: 9565029
Clin Microbiol Rev. 2006 Jan;19(1):111-26
pubmed: 16418526
Chem Rev. 2018 Apr 11;118(7):3862-3886
pubmed: 29561602
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Int J Parasitol Drugs Drug Resist. 2015 Dec;5(3):215-28
pubmed: 27120069
Nature. 2016 Sep 8;537(7619):229-233
pubmed: 27501246
PLoS Negl Trop Dis. 2016 Apr 15;10(4):e0004584
pubmed: 27082760
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
N Engl J Med. 2014 Sep 4;371(10):966
pubmed: 25184871
Acta Trop. 1979 Sep;36(3):289-92
pubmed: 43092

Auteurs

Richard J Wall (RJ)

Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Sandra Carvalho (S)

Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Rachel Milne (R)

Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Juan A Bueren-Calabuig (JA)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Sonia Moniz (S)

Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Juan Cantizani-Perez (J)

Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain.

Lorna MacLean (L)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Albane Kessler (A)

Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain.

Ignacio Cotillo (I)

Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain.

Lalitha Sastry (L)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Sujatha Manthri (S)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Stephen Patterson (S)

Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Fabio Zuccotto (F)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Stephen Thompson (S)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Julio Martin (J)

Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain.

Maria Marco (M)

Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain.

Timothy J Miles (TJ)

Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain.

Manu De Rycker (M)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Michael G Thomas (MG)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Alan H Fairlamb (AH)

Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Ian H Gilbert (IH)

Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Susan Wyllie (S)

Division of Biological Chemistry and Drug Discovery, Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH